IMTX logo

Immatics NV (IMTX)

Profile

Full Name

Immatics N.V.

Ticker Symbol

IMTX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

December 12, 2018

Indexes

Not included

Website

http://www.immatics.com

Employees

554

Key Details

Price

$4.26(+3.65%)

Market cap

$517.80M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$168.67M(+188.53% YoY)

Annual EPS

$0.15(+111.86% YoY)

PE ratio

38.38

Next earnings date

May 14, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.26
IMTX price is $4.26

30-Day Relative Volume

0.26
IMTX 30-day relative volume is 0.26

Price Performance

Price Today change

+3.65%
IMTX price is up +3.65% today

Price YTD change

-40.08%
IMTX price is down -40.08% since January 1st

Price 1-year change

-58.36%
IMTX price is down -58.36% year-on-year

Price 3-year change

-51.15%
IMTX price is down -51.15% over the past 3 years

Price Range

Price All-time high

$18.42
IMTX price is currently -76.87% below its historical high of $18.42

Price 3-year low

$3.30
IMTX price is currently +29.09% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$517.80M
IMTX market capitalization is $517.80 million

Market cap 3-year change

-5.63%
IMTX market capitalization is down -5.63% over the past 3 years

Market cap All-time high

$1.44B
IMTX market capitalization is currently -63.93% below its historical high of $1.44 billion

Market cap sector rank

69.74%
IMTX market capitalization is higher than 69.74% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+17.95%
IMTX shares outstanding is up +17.95% year-on-year

Shares Outstanding 3-Year Change

+93.16%
IMTX shares outstanding is up +93.16% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.16
IMTX beta is 1.16

200-day SMA

$8.30
IMTX price is currently -48.69% below its 200-day simple moving average

50-day SMA

$4.57
IMTX price is currently -6.71% below its 50-day simple moving average

RSI

48.53
IMTX 14-day relative strength index is 48.53

Volume

0.26
IMTX 30-day relative volume is 0.26

ATR

$0.36
IMTX average true range is $0.36

10-day Historical Volatility

107.41%
IMTX 10-day historical volatility is 107.41%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$168.67M
IMTX annual revenue is $168.67 million

Revenue Analysts estimate

$88.07M
IMTX annual revenue is currently +91.52% higher than the consensus analysts' forecast

Revenue 1-year change

+188.53%
IMTX annual revenue is up +188.53% year-on-year

Revenue Sector rank

61.48%
IMTX annual revenue is higher than 61.48% of companies in Healthcare sector

EPS

EPS

$0.15
IMTX annual earnings per share is $0.15

EPS Analysts estimate

-$1.34
IMTX annual earnings per share is currently -111.29% lower than the consensus analysts' forecast

EPS 1-year change

+111.86%
IMTX annual earnings per share is up +111.86% year-on-year

EPS Sector rank

84.38%
IMTX annual earnings per share is higher than 84.38% of companies in Healthcare sector

Profit

Gross profit

-
IMTX annual gross profit value is unknown

Gross margin

-
IMTX annual gross profit margin value is unknown

Operating profit

-$41.79M
IMTX annual operating income is -$41.79 million

Operating margin

-24.78%
IMTX annual operating profit margin is -24.78%

Net income

$16.47M
IMTX annual net profit is $16.47 million

Net margin

9.77%
IMTX annual net profit margin is 9.77%

Expenses

Total expenses

$210.46M
IMTX annual total expenses is $210.46 million

Operating expenses

$210.46M
IMTX annual total operating expenses is $210.46 million

Cost of goods sold

-
IMTX annual cost of goods sold value is unknown

Selling, general & administrative expenses

$50.27M
IMTX annual SGA is $50.27 million

Depreciation and amortization

$13.23M
IMTX annual depreciation & amortization is $13.23 million

Interest expense

$959.00K
IMTX annual interest expense is $959.00 thousand

Income tax

$6.63M
IMTX annual income tax is $6.63 million

EBIT & EBITDA

EBIT

$24.06M
IMTX annual earnings before interest & taxes is $24.06 million

EBITDA

$37.29M
IMTX annual EBITDA is $37.29 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$724.39M
IMTX annual total assets is $724.39 million

Non current assets

$69.29M
IMTX annual long term assets is $69.29 million

Current assets

$655.10M
IMTX annual total current assets is $655.10 million

Cash and cash equivalents

$246.35M
IMTX annual cash & cash equivalents is $246.35 million

Accounts receivable

$6.09M
IMTX annual accounts receivable is $6.09 million

Inventory

-
IMTX annual inventory value is unknown

Liabilities

Total liabilities

$126.23M
IMTX annual total liabilities is $126.23 million

Long term liabilities

$55.48M
IMTX annual total long term liabilities is $55.48 million

Current liabilities

$70.75M
IMTX annual total current liabilities is $70.75 million

Accounts payable

$10.52M
IMTX annual accounts payable is $10.52 million

Debt

Total debt

$16.86M
IMTX annual total debt is $16.86 million

Total debt 1-year change

-0.97%
IMTX annual total debt is down -0.97% year-on-year

Long term debt

$13.89M
IMTX annual long term debt is $13.89 million

Short term debt

$2.97M
IMTX annual short term debt is $2.97 million

Equity & Capital

Shareholders equity

$598.16M
IMTX annual stockholders equity is $598.16 million

Book value

$598.16M
IMTX annual book value is $598.16 million

Retained earnings

-$613.46M
IMTX annual retained earnings is -$613.46 million

Working capital

$584.35M
IMTX annual working capital is $584.35 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$171.04M
IMTX annual cash flow from operations is -$171.04 million

Cash from operations 1-year change

-966.76%
IMTX annual cash flow from operations is down -966.76% year-on-year

Cash from investing

-$164.94M
IMTX annual cash flow from investing activities is -$164.94 million

Cash from investing 1-year change

-385.38%
IMTX annual cash flow from investing activities is down -385.38% year-on-year

Cash from financing

$346.01M
IMTX annual cash flow from financing activities is $346.01 million

Cash from financing 1-year change

+278.16%
IMTX annual cash flow from financing activities is up +278.16% year-on-year

CAPEX

CAPEX

$17.84M
IMTX annual capital expenditures is $17.84 million

CAPEX 1-year change

-46.78%
IMTX annual capital expenditures is down -46.78% year-on-year

Free Cash Flow

Free cash flow

-$188.88M
IMTX annual free cash flow is -$188.88 million

Free cash flow 1-year change

-1270.64%
IMTX annual free cash flow is down -1270.64% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
IMTX annual gross profit margin value is unknown

Operating margin

-24.78%
IMTX annual operating profit margin is -24.78%

Net margin

9.77%
IMTX annual net profit margin is 9.77%

ROA & ROE

ROA

2.56%
IMTX annual return on assets is 2.56%

ROE

3.93%
IMTX annual return on equity is 3.93%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

38.38
IMTX price to earnings ratio is 38.38

PE ratio Sector rank

71.57%
IMTX price to earnings ratio is higher than 71.57% of companies in Healthcare sector

PB Ratio

PB ratio

0.87
IMTX price to book ratio is 0.87

PB ratio Sector rank

41.52%
IMTX price to book ratio is higher than 41.52% of companies in Healthcare sector

PS Ratio

PS ratio

3.07
IMTX price to sales ratio is 3.07

PS ratio Sector rank

53.08%
IMTX price to sales ratio is higher than 53.08% of companies in Healthcare sector

Enterprise value

Enterprise value

$288.31M
IMTX enterprise value is $288.31 million

Enterprise value Sector rank

62.51%
IMTX enterprise value is higher than 62.51% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

7.87
IMTX EV/EBITDA is 7.87

EV/EBITDA Sector rank

80.61%
IMTX EV/EBITDA is higher than 80.61% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

9.26
IMTX annual current ratio is 9.26

Quick ratio

-
IMTX annual quick ratio value is unknown

Leverage

Debt to equity

0.00
IMTX annual debt to equity ratio is 0.00

Interest coverage ratio

25.09
IMTX annual interest coverage ratio is 25.09

Risk & Stability

Piotroski F-Score

-
IMTX piotroski f-score value is unknown

Altman Z-Score

2.59
IMTX altman z-score is 2.59

Analyst ratings

Recent major analysts updates

Apr 1, 25 Cantor Fitzgerald
Overweight
Nov 19, 24 B of A Securities
Buy
Oct 7, 24 Piper Sandler
Overweight
Sep 9, 24 Cantor Fitzgerald
Overweight
Sep 5, 24 Cantor Fitzgerald
Overweight
May 16, 24 Mizuho
Buy
Nov 2, 23 Cantor Fitzgerald
Overweight
Mar 31, 23 Mizuho
Buy
Mar 23, 23 Chardan Capital
Buy
Aug 10, 22 Chardan Capital
Buy

Institutional Ownership

Similar stocks

PRTA logo
Prothena (PRTA)
AKBA logo
Akebia Therapeutics (AKBA)
OFIX logo
Orthofix Medical (OFIX)
SVRA logo
Savara (SVRA)
QURE logo
uniQure NV (QURE)
Niagen Bioscience (NAGE)
CDXC logo
ChromaDex (CDXC)
CRMD logo
CorMedix (CRMD)
KIDS logo
OrthoPediatrics (KIDS)
  • What is the ticker symbol for Immatics NV?
  • Does Immatics NV pay dividends?
  • What sector is Immatics NV in?
  • What industry is Immatics NV in?
  • What country is Immatics NV based in?
  • When did Immatics NV go public?
  • Is Immatics NV in the S&P 500?
  • Is Immatics NV in the NASDAQ 100?
  • Is Immatics NV in the Dow Jones?
  • When was Immatics NV's last earnings report?
  • When does Immatics NV report earnings?

What is the ticker symbol for Immatics NV?

The ticker symbol for Immatics NV is NASDAQ:IMTX

Does Immatics NV pay dividends?

No, Immatics NV does not pay dividends

What sector is Immatics NV in?

Immatics NV is in the Healthcare sector

What industry is Immatics NV in?

Immatics NV is in the Biotechnology industry

What country is Immatics NV based in?

Immatics NV is headquartered in Germany

When did Immatics NV go public?

Immatics NV's initial public offering (IPO) was on December 12, 2018

Is Immatics NV in the S&P 500?

No, Immatics NV is not included in the S&P 500 index

Is Immatics NV in the NASDAQ 100?

No, Immatics NV is not included in the NASDAQ 100 index

Is Immatics NV in the Dow Jones?

No, Immatics NV is not included in the Dow Jones index

When was Immatics NV's last earnings report?

Immatics NV's most recent earnings report was on Mar 27, 2025

When does Immatics NV report earnings?

The next expected earnings date for Immatics NV is May 14, 2025
On this page